| 1. |
- Hagel, Eva, et al.
(author)
-
PCBaSe Sweden : a register-based resource for prostate cancer research
- 2009
-
In: Scandinavian Journal of Urology and Nephrology. - London : Taylor & Francis. - 0036-5599 .- 1651-2065. ; 43:5, s. 342-9
-
Journal article (peer-reviewed)abstract
- Objective. To construct a database for clinical epidemiological prostate cancer research based on linkages between the National Prostate Cancer Register (NPCR) of Sweden, a population-based, nationwide quality database, and other nationwide registries. Material and methods. By use of the individually unique Swedish Personal Identity Number, the NPCR was linked to the Swedish Cancer Registry, the Cause of Death Register, the Prescribed Drug Register, the National Patient Register and the Acute Myocardial Infarction Register, all held at the Centre for Epidemiology at the National Board of Health and Welfare, and the Register of the Total Population, the Longitudinal Integration Database for Health Insurance and Labor Market Studies and the Multi-Generation Register, held at Statistics Sweden, and to the Swedish Hernia Register. Results. Record linkages between the NPCR and the Swedish Cancer Registry, the Cause of Death Register and the Register of the Total Population generated a database, named PCBaSe Sweden, including 80 079 prostate cancer cases, diagnosed between 1 January 1996 and 31 December 2006. Record linkage between PCBaSe Sweden and the Prescribed Drug Register generated 59 721 unique matches and linkage to the Acute Myocardial Infarction Register resulted in 11 459 matches. Conclusion. PCBaSe Sweden is a newly created and unique database with over 80 000 cases of prostate cancer with comprehensive data on inpatient and outpatient care, patterns of use of prescribed drugs and socioeconomic and familial factors. Many topics in clinical prostate cancer epidemiology can be investigated. using PCBaSe Sweden.
|
|
| 2. |
- Sepulveda-Falla, Diego, et al.
(author)
-
A multifactorial model of pathology for age of onset heterogeneity in familial Alzheimer's disease.
- 2021
-
In: Acta neuropathologica. - : Springer Science and Business Media LLC. - 1432-0533 .- 0001-6322. ; 141, s. 217-233
-
Journal article (peer-reviewed)abstract
- Presenilin-1 (PSEN1) mutations cause familial Alzheimer's disease (FAD) characterized by early age of onset (AoO). Examination of a large kindred harboring the PSEN1-E280A mutation reveals a range of AoO spanning 30years. The pathophysiological drivers and clinical impact of AoO variation in this population are unknown. We examined brains of 23 patients focusing on generation and deposition of beta-amyloid (Aβ) and Tau pathology profile. In 14 patients distributed at the extremes of AoO, we performed whole-exome capture to identify genotype-phenotype correlations. We also studied kinome activity, proteasome activity, and protein polyubiquitination in brain tissue, associating it with Tau phosphorylation profiles. PSEN1-E280A patients showed a bimodal distribution for AoO. Besides AoO, there were no clinical differences between analyzed groups. Despite the effect of mutant PSEN1 on production of Aβ, there were no relevant differences between groups in generation and deposition of Aβ. However, differences were found in hyperphosphorylated Tau (pTau) pathology, where early onset patients showed severe pathology with diffuse aggregation pattern associated with increased activation of stress kinases. In contrast, late-onset patients showed lesser pTau pathology and a distinctive kinase activity. Furthermore, we identified new protective genetic variants affecting ubiquitin-proteasome function in early onset patients, resulting in higher ubiquitin-dependent degradation of differentially phosphorylated Tau. In PSEN1-E280A carriers, altered γ-secretase activity and resulting Aβ accumulation are prerequisites for early AoO. However, Tau hyperphosphorylation pattern, and its degradation by the proteasome, drastically influences disease onset in individuals with otherwise similar Aβ pathology, hinting toward a multifactorial model of disease for FAD. In sporadic AD (SAD), a wide range of heterogeneity, also influenced by Tau pathology, has been identified. Thus, Tau-induced heterogeneity is a common feature in both AD variants, suggesting that a multi-target therapeutic approach should be used to treat AD.
|
|
| 3. |
- Tiensuu, Kiira, et al.
(author)
-
RAVEN: a student rocket program at Luleå University of Technology, Sweden
- 2021
-
In: IAC 2021 Congress Proceedings, 72nd International Astronautical Congress (IAC), Dubai, United Arab Emirates. - : International Astronautical Federation (IAF).
-
Conference paper (peer-reviewed)abstract
- RAVEN, Rocketry and Aerospace Vehicle Engineering in Norrbotten, is the first rocket project at Luleå University of Technology (LTU), Sweden. The project started in early 2020, and it aims to design, build, test and launch a hybrid propulsion rocket. The initial objectives are to reach an altitude of 10 km with an accompanying payload of 10 kg. The RAVEN team is based at the Kiruna Space Campus and consists of approximately 30 graduate students. The main goal of the first RAVEN rocket is to demonstrate its technology. The team is designing the entire rocket from scratch, including the hybrid propulsion system that uses nitrous oxide as the oxidising agent and paraffin as the solid fuel component, to produce approximately 6 kN of thrust. A modular rocket structure will offer customisation, enabling simple design changes in future iterations. Thus, the layout allows individual subsystems to be re-designed without changes directly affecting others. The project is meant to create a foundation for future student and research rocket projects at LTU. The follow-up developments could further iterate on the first rocket design, increasing hands-on education and providing more collaboration opportunities between the university and the aerospace industry – and eventually provide an in-house platform for research and education at the university or even for commercial start-ups. The infrastructure and resources, such as the proximity to the Esrange Space Center launch facility and support from the university and industry, make Northern Sweden an ideal location to establish a continuous rocket program.
|
|
